IRIDEX Corp (IRIX)
1.69
-0.08
(-4.52%)
USD |
NASDAQ |
Nov 15, 16:00
1.69
0.00 (0.00%)
After-Hours: 20:00
IRIDEX Research and Development Expense (TTM): 6.272M for June 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 6.272M |
| March 31, 2024 | 6.616M |
| December 31, 2023 | 6.829M |
| September 30, 2023 | 6.585M |
| June 30, 2023 | 6.731M |
| March 31, 2023 | 6.808M |
| December 31, 2022 | 7.175M |
| September 30, 2022 | 7.968M |
| June 30, 2022 | 8.069M |
| March 31, 2022 | 7.819M |
| December 31, 2021 | 6.868M |
| September 30, 2021 | 5.512M |
| June 30, 2021 | 4.593M |
| March 31, 2021 | 3.728M |
| December 31, 2020 | 3.282M |
| September 30, 2020 | 3.183M |
| June 30, 2020 | 3.321M |
| March 31, 2020 | 3.443M |
| December 31, 2019 | 3.682M |
| September 30, 2019 | 3.746M |
| June 30, 2019 | 3.888M |
| March 31, 2019 | 3.86M |
| December 31, 2018 | 4.006M |
| September 30, 2018 | 4.334M |
| June 30, 2018 | 4.505M |
| Date | Value |
|---|---|
| March 31, 2018 | 4.973M |
| December 31, 2017 | 5.208M |
| September 30, 2017 | 5.386M |
| June 30, 2017 | 5.322M |
| March 31, 2017 | 5.345M |
| December 31, 2016 | 5.365M |
| September 30, 2016 | 5.221M |
| June 30, 2016 | 5.202M |
| March 31, 2016 | 5.292M |
| December 31, 2015 | 5.214M |
| September 30, 2015 | 5.033M |
| June 30, 2015 | 4.892M |
| March 31, 2015 | 4.716M |
| December 31, 2014 | 4.629M |
| September 30, 2014 | 4.477M |
| June 30, 2014 | 4.304M |
| March 31, 2014 | 3.882M |
| December 31, 2013 | 3.684M |
| September 30, 2013 | 3.894M |
| June 30, 2013 | 3.977M |
| March 31, 2013 | 4.199M |
| December 31, 2012 | 4.385M |
| September 30, 2012 | 4.46M |
| June 30, 2012 | 4.348M |
| March 31, 2012 | 4.132M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
3.183M
Minimum
Sep 2020
8.069M
Maximum
Jun 2022
5.710M
Average
6.585M
Median
Sep 2023
Research and Development Expense (TTM) Benchmarks
| Cutera Inc | 18.38M |
| Stereotaxis Inc | 9.182M |
| Electromed Inc | 0.656M |
| Axogen Inc | 29.23M |
| Myomo Inc | 4.090M |